Latvia - Export of Heparin for Therapeutic Use
Since 2012, Latvia Export of Heparin for Therapeutic Use grew 8.1% year on year. In 2017, the country was number 63 comparing other countries in Export of Heparin for Therapeutic Use with $10,660.9. Latvia is overtaken by Estonia, which was ranked number 62 with $13,547.19 and is followed by Cyprus at $10,187.59. China topped the ranking with $1,237,456,257.9 in 2019, that is a decrease of 3% versus 2018. United States, France and Singapore respectively ranked number 2, 3 and 4 in this ranking. Montenegro recorded the best 5 years average growth at +490.8% per year, while Greenland recorded the worst performance at -78.9% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2017 | 10,660.90 |
| 2016 | 277.73 |
| 2015 | |
| 2014 | |
| 2013 |
Download all data from 1994 to 2017
How does Latvia rank in Export of Heparin for Therapeutic Use?
| # | 108 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
China
|
1,237,456,257.90 | 2019 | -3.0 % | +6.7 % | View data | |
| 2 |
#2
United States
|
528,184,315.05 | 2019 | +3.8 % | -15.3 % | View data | |
| 62 |
#62
Estonia
|
13,547.19 | 2019 | +9.3 % | +18.6 % | View data | |
| 63 |
#63
Latvia
|
10,660.90 | 2017 | +3,738.5 % | +8.1 % | View data | |
| 64 |
#64
Cyprus
|
10,187.59 | 2018 | NA | +138.2 % | View data | |